Posted On: 07/24/2016 11:47:56 AM
Post# of 1460
Anavex Presents 31-Week Safety Data from Phase 2a Study of ANAVEX 2-73 in Alzheimer’s Patients at AAIC 2016
Looking good,
Fletch
http://www.anavex.com/2016/?post_type=news
Looking good,
Fletch
http://www.anavex.com/2016/?post_type=news
(0)
(0)Scroll down for more posts ▼
